10085474|t|Effect of melatonin in selected populations of sleep-disturbed patients.
10085474|a|In an open pilot study on the efficacy of melatonin in the treatment of sleep disorders, patients with sleep disturbances alone, patients with sleep disturbances and signs of depression and patients with sleep disorders and dementia received 3 mg melatonin p.o. for 21 days, at bed time. After 2-3 days of treatment, melatonin significantly augmented sleep quality and decreased the number of awakening episodes in patients with sleep disturbances associated or not with depression. Estimates of next-day alertness improved significantly only in patients with primary insomnia. Agitated behavior at night (sundowning) decreased significantly in dementia patients. In a second retrospective study, 14 Alzheimer's disease (AD) patients received 9 mg melatonin daily for 22-35 months. A significant improvement of sleep quality was found, while there were no significant differences between initial and final neuropsychological evaluation (Functional Assessment Tool for AD, Mini-Mental). The results indicate that melatonin can be useful to treat sleep disturbances in elderly insomniacs and AD patients.
10085474	10	19	melatonin	Chemical	MESH:D008550
10085474	47	62	sleep-disturbed	Disease	MESH:D012893
10085474	63	71	patients	Species	9606
10085474	115	124	melatonin	Chemical	MESH:D008550
10085474	145	160	sleep disorders	Disease	MESH:D012893
10085474	162	170	patients	Species	9606
10085474	176	194	sleep disturbances	Disease	MESH:D012893
10085474	202	210	patients	Species	9606
10085474	216	234	sleep disturbances	Disease	MESH:D012893
10085474	248	258	depression	Disease	MESH:D003866
10085474	263	271	patients	Species	9606
10085474	277	292	sleep disorders	Disease	MESH:D012893
10085474	297	305	dementia	Disease	MESH:D003704
10085474	320	329	melatonin	Chemical	MESH:D008550
10085474	390	399	melatonin	Chemical	MESH:D008550
10085474	488	496	patients	Species	9606
10085474	502	520	sleep disturbances	Disease	MESH:D012893
10085474	544	554	depression	Disease	MESH:D003866
10085474	619	627	patients	Species	9606
10085474	633	649	primary insomnia	Disease	MESH:D007319
10085474	651	668	Agitated behavior	Disease	MESH:D011595
10085474	718	726	dementia	Disease	MESH:D003704
10085474	727	735	patients	Species	9606
10085474	773	792	Alzheimer's disease	Disease	MESH:D000544
10085474	794	796	AD	Disease	MESH:D000544
10085474	798	806	patients	Species	9606
10085474	821	830	melatonin	Chemical	MESH:D008550
10085474	1041	1043	AD	Disease	MESH:D000544
10085474	1085	1094	melatonin	Chemical	MESH:D008550
10085474	1118	1136	sleep disturbances	Disease	MESH:D012893
10085474	1148	1158	insomniacs	Disease	
10085474	1163	1165	AD	Disease	MESH:D000544
10085474	1166	1174	patients	Species	9606
10085474	Negative_Correlation	MESH:D008550	MESH:D003866
10085474	Negative_Correlation	MESH:D008550	MESH:D011595
10085474	Negative_Correlation	MESH:D008550	MESH:D003704
10085474	Negative_Correlation	MESH:D008550	MESH:D000544
10085474	Negative_Correlation	MESH:D008550	MESH:D007319
10085474	Negative_Correlation	MESH:D008550	MESH:D012893

